PV Bulletin

Use of AI in GXP Inspection Responses

MHRA guidance emphasizes accuracy in AI-generated responses to inspections, impacting workflows.

Primary source: Medicines and Healthcare products Regulatory Agency (MHRA)

PV Impact Brief

Urgency: HighConfidence: high

What changed

Organizations must implement quality checks for AI-generated content used in responses to ensure factual accuracy and compliance with MHRA standards.

Why it matters

Inaccurate information in submissions may lead to delays, increased scrutiny, or rejection of responses, placing a strain on resources and regulatory compliance.

Action needed

Implement mandatory quality checks and oversight for all AI-generated inspection responses to meet MHRA expectations for accuracy.

Relevant for
Regulatory Intelligence LeadPV Quality Lead
Processes impacted
Inspection ReadinessCAPA
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Guidance / Notice
Policy status
effective
Publication date
2026-06-29
Policy change
MHRA guidance published on the Inspectorate Blog regarding the use of Artificial Intelligence (AI) when drafting responses to GxP inspection findings.

Key changes

Establishes expectations for the use of AI in regulatory communications. Emphasizes that MAHs and sponsors are fully responsible for the accuracy of AI-generated content and warns against inaccuracies or 'hallucinations' in inspection responses.

Affected workflows

Inspection ReadinessCAPA

Responsible groups

Quality AssurancePV QualityCompliance Team

PV impact

Impacts inspection readiness and CAPA workflows. Organizations using AI for drafting responses must implement quality checks to ensure citations and factual claims are accurate to avoid regulatory non-compliance.

View regulator source

Source document details

Exact policy details

Responsibility for Accuracy
Organizations must ensure the accuracy of their submissions to the MHRA.
Applies to: All organizations submitting responses to MHRA.
Organisations have always been responsible for the accuracy of their responses to the MHRA and persons responsible for them have always been expected to verify factual claims. · p. 1 · High · Source
Expectations for Submission Accuracy
All submissions/responses must be factually accurate and verifiable.
Applies to: Applicable to all submissions to MHRA Compliance Teams.
All submissions/responses must be: factually accurate and verifiable. · p. 1 · High · Source
Impact of Inaccurate Information
Inaccurate submissions may lead to rejection or request for resubmission.
Applies to: Responses to MHRA inspections.
if the information supplied in response to an inspection is inaccurate, incomplete or overly verbose then we may reject the response or return it for another attempt. · p. 1 · High · Source
Disclosure of AI Use
Organizations can voluntarily disclose AI use in submissions.
Applies to: Applicable to organizations using AI in responses.
we are offering organisations the option to disclose AI use in responses/submissions to the compliance teams. · p. 1 · High · Source

Workflow rule impacts

Inspection ReadinessCompliance Teams

Increased scrutiny of submissions and potential resource strain if AI tools are misused.

Expectations for accuracy and oversight are higher due to AI tool usage.

As AI becomes more sophisticated, this framework remains relevant because it focuses on accountability and process. · p. 1 · High · Source

Evidence and confidence

Confidence: highSource updated: Jun 29, 2026

Full briefing

Practical implication

Implement mandatory quality checks and oversight for all AI-generated inspection responses to meet MHRA expectations for accuracy.

The MHRA has released guidance on the use of AI in drafting responses to GxP inspection findings. It underscores that organizations are fully accountable for the accuracy of AI-generated content, warning against inaccuracies that could lead to regulatory non-compliance. The guidance includes higher expectations for submission accuracy due to the use of AI, impacting inspection readiness and corrective action preventive action (CAPA) processes.

What changed: Organizations must implement quality checks for AI-generated content used in responses to ensure factual accuracy and compliance with MHRA standards.

Why it matters: Inaccurate information in submissions may lead to delays, increased scrutiny, or rejection of responses, placing a strain on resources and regulatory compliance.

Practical implication: Implement mandatory quality checks and oversight for all AI-generated inspection responses to meet MHRA expectations for accuracy.

View original source

Published from the Firecrawl policy change extraction pipeline.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Urgent Withdrawal of Reusable da Vinci S and Si Instruments Due to Cable Degradation

Urgency: High

Healthcare facilities must isolate the affected instruments and notify Intuitive Surgical for returns while preparing for potential delays in surgical procedures due to instrument replacements.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward